Cited by 32Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationProtein Tyrosine Phosphatases

Il-1r1 drives leukemogenesis induced by Tet2 loss

Open access
Burns, Sarah S., Kumar, Ramesh, Pasupuleti, Santhosh Kumar, So, Kaman, Zhang, Chi, Kapur, Reuben·2022·Leukemia

Abstract

Loss of the ten-eleven translocation methylcytosine dioxygenase 2 ( Tet2 ) gene, which is commonly mutated in hematological malignancies, dysregulates inflammatory pathways, including the interleukin-1 (IL-1) pathway [ 1 , 2 , 3 ]. Roles for IL-1 signaling have been reported in terminally differentiated hematopoietic cells and in non-cell autonomous contexts [ 3 , 4 ]. However, our group demonstrated that inhibition of inflammatory pathways can suppress clonal hematopoiesis (CH), indicating potential direct roles for hematopoietic stem and progenitor cells (HSPCs) in inflammation [ 5 ]. As TET2 mutations are often present in HSPCs and provide these cells with a competitive advantage, dysregulation of the IL-1 pathway in HSPCs may contribute to leukemogenesis and may catalyze the progression of preleukemic states to malignancy [ 6 ].

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41375-022-01665-3

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 16 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Burns, S. S., Kumar, R., Pasupuleti, S. K., So, K., Zhang, C., & Kapur, R.
Affiliations
  • Indiana University Indianapolis (US)
  • Indiana University – Purdue University Indianapolis (US)
Corresponding author
Kapur, Reuben
Venue
Leukemia
Published
2022-08-12
Volume
36
Issue
10
Pages
2531-2534
ISSN
  • 0887-6924 (ISSN-L)
  • 1476-5551
OpenAlex
W4290839656
Cited by
32
References
16
Citations by year
2026: 7 · 2025: 5 · 2024: 10 · 2023: 8 · 2022: 2
FWCI
4.55
Type
journal article
Language
en
Open access
Locations
  • Leukemia (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion, cc-by)
Funders
U.S. Department of Health & Human Services | National Institutes of Health (T32 DK007519, R01 CA173852, R01 CA134777, R01 HL146137, R01 HL140961)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
IL1R1, IL-1 signaling, TET2 mutation, leukemogenesis, clonal hematopoiesis, hematopoietic stem and progenitor cells, inflammation, preleukemic state, hematologic malignancies
MeSH terms
DNA-Binding Proteins, Leukemia, Signal Transduction, Dioxygenases, Receptors, Interleukin-1 Type I, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review